Stocks · Financials · Blank Checks

Oaktree Acquisition Corp. III Life Sciences

OACC Clue Score59
United States Fiscal year ends December CIK 0002029769
$10.75 -0.09% Close, 9 Oct 2026
Price $10.75 +1.70% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 16 Dec 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2025Operating income−1.2Net income7.3
FY2025
Operating income −1.2
Net income 7.3
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2025Operating cash flow−0.4
FY2025
Operating cash flow −0.4

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2025Cash1.4Shareholders’ equity−6.8
FY2025
Cash 1.4
Shareholders’ equity −6.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2025 31 Dec 2025
Returns
3.6%
Balance and payout
4.1%